Obtained U.S. FDA 510(k) clearance for a medical device
- Announcement Date
- 03/20/2026
- Date of Occurrence
- 03/20/2026
- Applicable Clause
- Paragraph 53
1. Date of occurrence: March 20, 2026
2. Company name: HMD Biomedical Inc.
3. Relationship with the Company: The Company
4. Cause of occurrence: The Company's blood glucose monitoring system obtained U.S. FDA 510(k) clearance.
5. Countermeasures: Proceed with the planned market rollout.
6. Other matters: None